The integration of population-scale biobanks, polygenic risk scoring (PRS), and edge-AI analytical pipelines marks the future scope of the AI in Genomics Market. National health initiatives are sequencing millions of genomes, generating massive datasets that require AI architectures for clinical risk stratification. In addition, applying machine learning models to polygenic risk scoring...